HPV Vaccine Cuts Cervical Deaths

A recent study from Queen Mary University of London has shown that the Human Papillomavirus (HPV) vaccine is highly effective in reducing cervical cancer-related deaths among young women. The research indicated that girls who received the vaccine at ages 12-13 experienced a decrease in mortality before the age of thirty. There was also a historic drop in cervical cancer deaths among the 20-24 age group between 2020 and 2024, with no reported deaths in that group. It is estimated that the vaccine has helped save approximately 200 lives in England. The vaccination is recommended for children aged 11-13 before the onset of sexual activity, but regular screenings should continue. Additionally, efforts to vaccinate boys should be intensified to limit the spread of the virus and reduce the risk of related cancers.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل